Catalyst Compounds TB-500 Capsules

Description

This oral capsule format delivers TB-500, a synthetic fragment of the actin-binding protein thymosin beta-4, in a research-convenient solid-dose preparation. Researchers use it to examine cytoskeletal regulation and cell migration.

Investigations span angiogenesis, cellular motility, extracellular matrix turnover, and inflammatory modulation in cultured systems and animal models. The encapsulated form supports oral-route study designs and simplified handling in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.